🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Progress Software

5 posts
Read More

Progress Software (NASDAQ: PRGS) slips after Q3 revenue miss as $400m Domo deal resets FY26

Progress Software beat third-quarter earnings expectations and lifted full-year guidance after completing its $400 million purchase of Domo’s operating business, but a small revenue miss sent the stock lower after hours. Investors now need to judge whether acquiring more than 2,400 Domo customers can accelerate AI-data growth without undermining Progress Software’s acquisition discipline.